GLP-1/GIP meds can help reduce the risk of stroke, heart attack, and heart failure
According to their structure, they can be divided into those of human origin, those synthesized from modifications of active fragments of physiological GLP1, and those generated by replicating the structure of exendin-4, a natural 39-amino acid peptide naturally resistant to the action of the DPP-4 enzyme 15
More people hit bigger weight-loss milestones A larger share of tirzepatide users reach 10%, 15%, and 20%+ total weight loss than semaglutide users at comparable time points, though plenty of people reach those same milestones on semaglutide too individual response varies a lot
Iron deficiency anemia is common, reducing the oxygen-carrying capacity of the blood, which directly suffocates the muscle tissues during exertion